Clinical trials
Recruiting Phase 3 trials in Lithuania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 21 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 4 |
| Takeda | 4 |
| Amgen | 3 |
| Boehringer Ingelheim | 3 |
| Merck Sharp & Dohme LLC | 3 |
| AMAG Pharmaceuticals, Inc. | 2 |
| Neurocrine Biosciences | 2 |
| Octapharma | 2 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 2 |
| 4D Molecular Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 6 |
| Crohn Disease | 4 |
| Renal Insufficiency, Chronic | 4 |
| Anemia | 3 |
| Colitis, Ulcerative | 3 |
| Major Depressive Disorder | 3 |
| Anemia, Iron-Deficiency | 2 |
| Endometrial Neoplasms | 2 |
| Leukemia | 2 |
| Multiple Sclerosis, Chronic Progressive | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.